Journal of Hepatocellular Carcinoma
Volume 10, 2023 - Issue
ORIGINAL RESEARCH
Efficacy and Safety of TACE Combined with Lenvatinib and PD-(L)1 Inhibitor in the Treatment of Unresectable Hepatocellular Carcinoma: A Retrospective Study
Hui YangDepartment of Interventional Therapy, Ningbo NO.2 Hospital, Ningbo, Zhejiang, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0009-0008-9003-1025View further author information
https://orcid.org/0009-0008-9003-1025View further author information, Tiequan YangDepartment of Interventional Therapy, Ningbo NO.2 Hospital, Ningbo, Zhejiang, People’s Republic of Chinahttps://orcid.org/0009-0001-2488-9532View further author information
https://orcid.org/0009-0001-2488-9532View further author information, Guangpin QiuDepartment of Interventional Therapy, Ningbo NO.2 Hospital, Ningbo, Zhejiang, People’s Republic of Chinahttps://orcid.org/0009-0002-7097-4081View further author information
https://orcid.org/0009-0002-7097-4081View further author information & Jie LiuDepartment of Interventional Therapy, Ningbo NO.2 Hospital, Ningbo, Zhejiang, People’s Republic of Chinahttps://orcid.org/0009-0001-0952-632XView further author information
https://orcid.org/0009-0001-0952-632XView further author information